ADIL · Adial Pharmaceuticals, Inc. · Exempt Offerings
$4.86
-0.35 (-6.72%)
At close · Sep 18
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.13M
Shares
2.63M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-12-03 | New | Pharmaceuticals | $4,285,289 | $4,285,289 | 06b |
| 2025-05-14 | New | Pharmaceuticals | $4,815,379 | $4,815,379 | 06b |
| 2024-03-14 | New | Pharmaceuticals | $287,500 | $287,500 | 06b |
| 2023-10-26 | New | Pharmaceuticals | $3,998,582 | $3,998,582 | 06b |
| 2023-06-05 | New | Pharmaceuticals | $3,052,500 | $52,500 | 06b |
| 2023-03-06 | New | Pharmaceuticals | $61,603 | $61,603 | 06b |
| 2022-02-17 | New | Pharmaceuticals | $10,000,000 | $10,000,000 | 06b |
| 2021-07-12 | New | Pharmaceuticals | $5,000,000 | $500,004 | 06b |
| 2021-03-26 | New | Pharmaceuticals | $2,100,003 | $291,003 | 06b |
| 2020-11-30 | New | Pharmaceuticals | $15,295,750 | $295,750 | 06b |
| 2020-09-25 | New | Pharmaceuticals | $500,000 | $500,000 | 06b |
| 2020-06-17 | New | Pharmaceuticals | $5,217,000 | $5,217,000 | 06b |
Showing 1–12 of 12 filings